FDA approves Varithena for the treatment of patients with varicose veins

BTG plc (LSE: BTG), the specialist healthcare company, has announced that the US Food and Drug Administration (FDA) has approved Varithena™ (polidocanol injectable foam) for the treatment of patients with incompetent veins and visible varicosities of the great saphenous vein (GSV) system.1 Varithena™ (formerly known as Varisolve PEM) is a pharmaceutical-grade, low-nitrogen, polidocanol foam dispensed from a proprietary canister device. via Health News from Medical News Today Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/11/fda-approves-varithena-for-treatment-of.html